Zoleko-Manego R, Okwu DG, Handrich C, Dimessa-Mbadinga LB, Akinosho MA, NdzebeNdoumba WF, Davi SD, Stelzl D, Veletzky L, Kreidenweiss A, Nordmann T, Adegnika AA, Lell B,
Kremsner PG, Ramharter M, Mombo-Ngoma G. Effectiveness of antimalarial drug
combinations in treating concomitant urogenital schistosomiasis in malaria patients in
Lambaréné, Gabon: A non-randomised event-monitoring study. PLoS Negl Trop Dis. 2022
Oct;16(10):e0010899.
Honkpehedji YJ, Adegnika AA, Dejon-Agobe JC, Zinsou JF, …T, Sicuri E, Schwarz NG, Corstjens
PLAM, Hoekstra PT, van Dam GJ, Kreidenweiss A, freeBILy Consortium. Prospective,
observational study to assess the performance of CAA measurement as a diagnostic tool for
the detection of Schistosoma haematobium infections in pregnant women and their child in
Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon. BMC infectious
diseases. 2020 Sep 29;20(1):718.
Nouatin O, Mengue JB, Dejon-Agobé JC, Fendel R, Ibáñez J, Ngoa UA, Edoa JR, Adégbité BR,
Honkpéhédji YJ, Zinsou JF, Hounkpatin AB, Moutairou K, Homoet A, Esen M, Kreidenweiss A,
Hoffman SL, Theisen M, Luty AJF, Lell B, Agnandji ST, Mombo-Ngoma G, Ramharter M,
Kremsner P, Mordmüller B, Adegnika AA. Exploratory analysis of the effect of helminth
infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine
candidate GMZ2. PLoS Negl Trop Dis. 2021 Jun 1;15(6):e0009361.
Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R,
Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados González MA,
Gorini N, Grobusch MP, Vico M, Oostvogels L et al , HERALD Study Group. Efficacy and safety of
the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin
America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Lancet Infect Dis. 2021 Nov 23;S1473-3099(21)00677-0.
Fusco D, Rakotozandrindrainy R, Rakotoarivelo RA, Andrianarivelo MR, Rakotozandrindrainy
N, Rasamoelina T, …, Kreidenweiss A, Hoekstra PT, Adegnika AA, Sicuri E, Corstjens PLAM, van
Dam GJ, May J, Schwarz NG, freeBILy consortium. A cluster randomized controlled trial for
assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant
women and their young children: study protocol of the freeBILy clinical trial in Madagascar.
Trials. 2021 Nov 20;22(1):822.
Cirera L, Castelló JV, Brew J, Saúte F, Sicuri E. The impact of a malaria elimination initiative on
school outcomes: Evidence from Southern Mozambique. Econ Hum Biol. 2022 Jan;44:101100.
doi: 10.1016/j.ehb.2021.101100
Hoekstra PT, Schwarz NG, Adegnika AA, Andrianarivelo MR, Corstjens PLAM,
Rakotoarivelo RA, Rakotozandrindrainy R, Sicuri E, Kreidenweiss A, van Dam GJ; freeBILy
consortium. Fast and reliable easy-to-use diagnostics for eliminating bilharzia in young
children and mothers: An introduction to the freeBILy project. Acta Trop. 2020 Nov;211:105631.
doi: 10.1016/j.actatropica.2020.105631.
Sicuri E, Bardají A, Sigauque B, Maixenchs M, Nhacolo A, Nhalungo D, Macete E, Alonso PL,
Menéndez C. Costs associated with low birth weight in a rural area of Southern Mozambique.
PLoS One. 2011;6(12):e28744. doi:
10.1371/journal.pone.0028744.
Sicuri E, Fernandes S, Macete E, González R, Mombo-Ngoma G, Massougbodgi A, Abdulla S,
Kuwawenaruwa A, Katana A, Desai M, Cot M, Ramharter M, Kremsner P, Slustker L, Aponte J,
Hanson K, Menéndez C. Economic evaluation of an alternative drug to sulfadoxinepyrimethamine as intermittent preventive treatment of malaria in pregnancy. PLoS One. 2015
Apr 27;10(4):e0125072. doi:
10.1371/journal.pone.0125072.
Fernandes S, Sicuri E, Kayentao K, van Eijk AM, Hill J, Webster J, Were V,
Akazili J, Madanitsa M, ter Kuile FO, Hanson K. Cost-effectiveness of two versus three or more
doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan
Africa: a modelling study of meta-analysis and cost data. Lancet Glob Health. 2015
Mar;3(3):e143-53. doi:
10.1016/S2214-109X(14)70385-7.
González, Raquel, et al. "Safety and efficacy of dihydroartemisinin–piperaquine for
intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and
Mozambique: a randomised, double-blind, placebo-controlled trial." The Lancet Infectious
Diseases 24.5 (2024): 476-487
Nguema Moure, Paul Alvyn, et al. "A randomized assessors-blind clinical trial to evaluate the
safety and the efficacy of albendazole alone and in combination with mebendazole or
pyrantel for the treatment of Trichuris trichiura infection in school-aged children in Lambaréné
and surroundings." Antimicrobial Agents and Chemotherapy 68.5 (2024): e01211-23.
Groger, Mirjam, et al. "Pharmacokinetics of ribavirin in the treatment of Lassa fever: an
observational clinical study at the Irrua specialist teaching hospital, Edo State, Nigeria."
Clinical Infectious Diseases 76.3 (2023): e841-e848.
Tona Lutete, Gaston, et al. "Pyronaridine–artesunate real-world safety, tolerability, and
effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event
monitoring study." PLoS medicine 18.6 (2021): e1003669.
Ramharter, Michael, et al. "Population pharmacokinetics of mefloquine intermittent
preventive treatment for malaria in pregnancy in Gabon." Antimicrobial Agents and
Chemotherapy 63.2 (2019): 10-1128.
Dejon-Agobé JC, Edoa JR, Honkpehedji YJ, Zinsou JF, Adégbitè BR, Ngwese MM, Mangaboula
A, Lell B, Grobusch MP, Mordmüller B, Adegnika AA. Schistosoma haematobium infection
morbidity, praziquantel effectiveness and reinfection rate among children and young adults in
Gabon. Parasit Vectors. 2019 Dec 10;12(1):577. doi: 10.1186/s13071-019-3836-6
Mombo-Ngoma G, Honkpehedji J, Basra A, Mackanga JR, Zoleko RM, Zinsou J, Agobe
JC, Lell B, Matsiegui PB, Gonzales R, Agnandji ST, Yazdanbakhsh M, Menendez C, Kremsner PG,
Adegnika AA, Ramharter M. Urogenital schistosomiasis during pregnancy is associated with
low birth weight delivery: analysis of a prospective cohort of pregnant women and their
offspring in Gabon., Int J Parasitol. 2016 Dec 18. pii: S0020-7519(16)30270-3. doi: 10.1016 /
j.ijpara. 2016.11.001
Adegnika AA, Zinsou JF, Issifou S, Ateba-Ngoa U, Kassa RF, Feugap EN, Honkpehedji YJ, Dejon
Agobe JC, Kenguele HM, Massinga-Loembe M, Agnandji ST, Mordmüller B, Ramharter M,
Yazdanbakhsh M, Kremsner PG, Lell B. Randomized, Controlled, Assessor-Blind Clinical Trial To
Assess the Efficacy of Single- versus Repeated-Dose Albendazole To Treat Ascaris lumbricoides,
Trichuris trichiura, and Hookworm Infection. Antimicrob Agents Chemother. 2014
May;58(5):2535-40.
Basra A, Mombo-Ngoma G, Capan Melser M, Akerey Diop D, Würbel H, Mackanga JR,
Fürstenau M, Manego Zoleko R, Adegnika AA, Gonzalez R, Menendez C, Kremsner
PG,Ramharter M. Efficacy of Mefloquine Intermittent Preventive Treatment in Pregnancy
Against Schistosoma haematobium Infection in Gabon: A Nested Randomized Controlled
Assessor-Blinded Clinical Trial. Clin Infect Dis. 2013 Mar;56(6):e68-75. doi:2
Adegnika AA, Breitling LP, Agnandji ST, Chai SK, Schütte D, Oyakhirome S, Schwarz NG,
Grobusch MP, Missinou MA, Ramharter M, Issifou S, Kremsner PG. Effectiveness of quinine
monotherapy for treating Plasmodium falciparum infection in pregnant women in
Lambarene, Gabon, Am J Trop Med Hyg. 2005 Aug; 73(2):263-266.
Ntoumi F, Nachega JB, Aklillu E, Chakaya J, Felker I, Amanullah F, Yeboah-Manu D, Castro KG,
Zumla A. World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to
save lives and to end tuberculosis. The Lancet Infectious Diseases. 2022 Mar
3:S1473-3099(22)00142-6. doi: 10.1016/S1473-3099(22)00142-6
Ntoumi F and Zumla A. 2022. Advancing accurate metrics for future pandemic preparedness.
The Lancet. Vol 399 April 16, 2022. 1443-1445.
Ntoumi F. From mink to malaria. 2022. Nature Microbiology Mar;7(3):343-344. doi:
10.1038/41564-022-01062-7
Edwards SJL, Silaigwana B, Asogun D, Mugwagwa J, Ntoumi F, Ansumana R, Bardosh K, Ambe
J. 2022. An ethics of anthropology-informed community engagement with COVID-19 clinical
trials in Africa. Developing World Bioethics. 2022 Aug 9 : 1-10. doi: 10.1111/dewb.12367
Mwatondo A, Rahman-Shepherd A, Hollmann L, Chiossi S, Maina J, Kurup KK, Hassan OA,
Coates B, Khan M, Spencer J, Mutono N, Thumbi SM, Muturi M, Mutunga M, Arruda LB, Akhbari
M, Ettehad D, Ntoumi F, Scott TP, Nel LH, Ellis-Iversen J, Sönksen UW, Onyango D, Ismail Z,
Simachew K, Wolking D, Kazwala R, Sijali Z, Bett B, Heymann D, Kock R, Zumla A, Dar O. 20234.
A global analysis of One Health Networks and the proliferation of One Health collaborations.
The Lancet. 2023 Jan 19:S0140-6736(22)01596-3.
Enable Protocol authorship group. A prospective, multi-site, cohort study to estimate incidence
of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa
research programme)-Study protocol. PLoS One. 2023 Mar 30;18(3):e0283643. doi: 10.1371/
journal.pone.0283643. PMID: 36996258; PMCID: PMC10062557.
P. falciparum msp1 and msp2 genetic diversity in P. falciparum single and mixed infection
with P. malariae among the asymptomatic population in Southern Benin. Parasitol Int. 2022
Aug;89:102590. doi: 10.1016/j.parint.2022.102590. Epub 2022 Apr 25. PMID: 35472441.
Surveillance of Plasmodium malariae infection among inhabitants of rural areas in OuidahKpomasse-Tori Bossito health district, Benin. Parasitol Res. 2022 Jan;121(1):275-286. doi:
10.1007/s00436-021-07398-z. Epub 2022 Jan 4. PMID: 34981216.
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC,
A Vaccine Candidate to Prevent Pregnancy-associated Malaria. Clin Infect Dis. 2019 Oct
15;69(9):1509-1516. doi: 10.1093/cid/ciy1140. PMID: 30629148; PMCID: PMC6792113.
Bassat Q, Maïga-Ascofaré O, May J, Clain J, Mombo-Ngoma G, Groger M, Adegnika AA, Agobé
JD, Djimde A, Mischlinger J, Ramharter M; ASAAP and Multimal Consortia. Challenges in the
clinical development pathway for triple and multiple drug combinations in the treatment of
uncomplicated falciparum malaria.
Malar J. 2022; 21(1):61.
RECOVERY Collaborative Group. Higher dose corticosteroids in patients admitted to hospital
with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a
randomised, controlled, open-label, platform trial.
Lancet. 2023 May 6;401(10387):1499-1507.
Behrens HM, Schmidt S, Henshall IG, López-Barona P, Peigney D, Sabitzki R, May J, MaïgaAscofaré O, Spielmann T. Impact of different mutations on Kelch13 protein levels, ART
resistance, and fitness cost in Plasmodium falciparum parasites. mBio. 2024 Jun
12;15(6):e0198123. doi: 10.1128/mbio.01981-23.
Maïga-Ascofaré O, Rakotozandrindrainy R, Girmann M, Hahn A, Randriamampionona N,
Poppert S, May J, Schwarz NG. Molecular epidemiology and seroprevalence in asymptomatic
Plasmodium falciparum infections of Malagasy pregnant women in the highlands. Malar J.
2015:14:188.
Krumkamp R, Aldrich C, Maiga-Ascofare O, Mbwana J, Rakotozandrindrainy N, Borrmann S,
Caccio SM, Rakotozandrindrainy R, Adegnika AA, Lusingu JPA, Amuasi J, May J, Eibach D;
CRYPTO study group. Transmission of Cryptosporidium spp. among human and animal local
contact networks in sub-Saharan Africa: a multi-country study. Clin Infect Dis. 2020. pii:
ciaa223.
